TRIAL DETAIL

A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy (AXAGIST)

Drug:
Trial Name:
A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy (AXAGIST)
NCT#:
Conditions:
Gastrointestinal Stromal Tumor
Status:
Recruiting
Phase:
2
Start Date 04/30/2019
Age of Trial (yrs) 1.3
Treatment Phase:
Gleevec-resistant
Drug Category:
PD-L1 + KIT inhibitor
Strategy:
Trial Type:
Specifically GIST and only GIST
Other Protocol IDs:
AXAGIST
Sponsor:
Maria Sklodowska-Curie Institute - Oncology Center
Patient Contact:
Elzbieta Bylina, MSc 22546 21 03 ext 0048 elzbieta.bylina@coi.pl Katarzyna Kozak, MD 225462172 ext 0048 katarzyna.kozak@coi.pl
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral Intravenous
Trial Notes:

Trial Links

Trial Results

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
Warsaw
Poland